Wei H, Zhou C, Lin D, Liu B, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Chen J, Zhang J, Jin J, Qiu S, Gu R, Wang Y, Mi Y, Wang J. Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia. haematol [Internet]. 2021Apr.30 [cited 2024Nov.28];106(5):1491-5. Available from: https://haematologica.org/article/view/haematol.2020.267526